# Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial

> **NCT07120776** · NA · NOT_YET_RECRUITING · sponsor: **University of Manchester** · enrollment: 75 (estimated)

## Conditions studied

- Hypertrophic Obstructive Cardiomyopathy \(HOCM\)
- Left Ventricular Outflow Tract Obstruction
- Myocardial Ischaemia

## Interventions

- **DRUG:** Camzyos (Mavacamten)

## Key facts

- **NCT ID:** NCT07120776
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-05
- **Final completion:** 2027-09
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07120776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07120776, "Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07120776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*